Subscribe to the BioNews newsletter for free

Login
Advanced Search

Search for
BioNews

Like the Progress Educational Trust on Facebook


 


 

Gene therapy restores vision in blind mice

09 October 2017

By Dr Kimberley Bryon-Dodd

Appeared in BioNews 921

Gene therapy has restored some vision in mice blinded by retinitis pigmentosa, an inherited degenerative eye disease.

Retinitis pigmentosa is the most common cause of blindness in young people, and no effective treatments currently exist for patients with little sight left.

'There are many blind patients in our clinics and the ability to give them some sight back with a relatively simple genetic procedure is very exciting,' said Dr Samantha de Silva at the University of Oxford, the lead author of the study.

Diseases like retinitis pigmentosa cause gradual loss of light-sensitive cells in the eye's retina, eventually leading to blindness. Rather than trying to restore these cells, researchers used a viral vector to introduce a gene for melanopsin, a light-sensitive protein naturally found in the eye, into the remaining retinal cells.

The cells then produced melanopsin and became able to sense and respond to light, and send visual signals to the brain. The changes lasted longer than a year, around the lifetime of the mice used in the study.

'Our next step will be to start a clinical trial to assess this in patients,' said Dr de Silva.

The authors are hopeful that this common form of blindness may be able to at least be partially restored in the future by using this gene therapy technique.

'The effect of retinitis pigmentosa on families with the disease is devastating and we have spent many years working out new ways to slow the loss of sight and to begin restoring it,' said Professor Robert MacLaren also at the University of Oxford, whose group led the research. 'This new approach is exciting because by using a human protein that is already present in the eye we reduce the chances of causing an immune response.'

Professor Alan Boyd, President of the Faculty of Pharmaceutical Medicine of the Royal College of Physicians, who was not involved in the study, said that no satisfactory treatments currently exist for patients with end-stage retinal degeneration, who have little sight left. Although human clinical trials could be a minimum of two to three years away, he said: 'These results are very encouraging and could lead to a potential treatment for end-stage blindness in humans.'

The study was published in the journal PNAS.

RELATED ARTICLES FROM THE BIONEWS ARCHIVE

16 October 2017 - by Rikita Patel 
The US Food Drug and Administration advisory committee has backed the use of gene therapy to treat a hereditary disease for the first time...

22 May 2017 - by Dr Kimberley Bryon-Dodd 
A small, preliminary clinical trial has demonstrated safe and well-tolerated gene therapy to treat wet age-related macular degeneration...
03 May 2016 - by Sarah Gregory 
A trial of gene therapy for choroideremia, a rare form of inherited blindness, has partially restored the vision of several patients...
01 February 2016 - by Kulraj Singh Bhangra 
Researchers have used the CRISPR/Cas9 genome-editing technique to correct a genetic mutation that causes blindness...
24 August 2015 - by Antony Blackburn-Starza 
An experimental form of gene therapy to treat blindness has been showed to restore some vision in mice....
15 December 2014 - by Dr Rosie Gilchrist 
Scientists have used gene therapy to restore some sight to animals with visual impairment similar to retinosa pigmentosa, a type of human blindness...

HAVE YOUR SAY
Be the first to have your say.

You need to or  to add comments.

By posting a comment you agree to abide by the BioNews terms and conditions


- click here to enquire about using this story.

Published by the Progress Educational Trust

CROSSING FRONTIERS

Public Conference
London
8 December 2017

Speakers include

Professor Azim Surani

Professor Magdalena Zernicka-Goetz

Professor Robin Lovell-Badge

Sally Cheshire

Professor Guido Pennings

Katherine Littler

Professor Allan Pacey

Dr Sue Avery

Professor Richard Anderson

Dr Elizabeth Garner

Dr Andy Greenfield

Dr Anna Smajdor

Dr Henry Malter

Vivienne Parry

Dr Helen O'Neill

Dr César Palacios-González

Philippa Taylor

Fiona Fox

Sarah Norcross

Sandy Starr


BOOK HERE

Good Fundraising Code

Become a Friend of PET HERE and give the Progress Educational Trust a regular donation